Understanding Clinical Study Experiences for Pulmonary Fibrosis Patients
This study aims to understand what helps or hinders people with pulmonary fibrosis (a lung disease that causes scarring of the lungs) from joining or finishing clinical studies. It's an observational study, meaning you won't receive any new treatments. Instead, researchers will collect information about your experiences. They want to find out how many patients decide to join a study and how many complete it. This information will help improve future studies for people with pulmonary fibrosis. You can join if you are at least 18 years old and have a diagnosis of pulmonary fibrosis. The study plans to include 500 participants.
- Study design
- This is an observational study, meaning no interventions are given. It aims to enroll 500 participants to understand their experiences in clinical studies.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- The study will measure patient participation at 3 months and completion rates at 12 months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Pinpointing the Factors Affecting Clinical Study Experiences of Pulmonary Fibrosis Patients
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Michael B Gill · STUDY_DIRECTOR · Power Life Sciences Inc.
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Number of pulmonary fibrosis patients who decide to participate in a clinical study3 months
- Rate of patients who remain in an pulmonary fibrosis clinical study to completion12 months